Felix Kratz
2017
In 2017, Felix Kratz earned a total compensation of $331.4K as Vice President – Drug Development at CytRx.
Compensation breakdown
Bonus | $76,000 |
---|---|
Option Awards | $33,000 |
Salary | $222,400 |
Total | $331,400 |
Kratz received $222.4K in salary, accounting for 67% of the total pay in 2017.
Kratz also received $76K in bonus and $33K in option awards.
Rankings
In 2017, Felix Kratz's compensation ranked 13,090th out of 14,666 executives tracked by ExecPay. In other words, Kratz earned more than 10.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 13,090 out of 14,666 | 11th |
Division Manufacturing | 5,158 out of 5,772 | 11th |
Major group Chemicals And Allied Products | 1,873 out of 2,075 | 10th |
Industry group Drugs | 1,561 out of 1,731 | 10th |
Industry Biological Products, Except Diagnostic Substances | 284 out of 313 | 9th |
Source: SEC filing on June 26, 2019.
Kratz's colleagues
We found two more compensation records of executives who worked with Felix Kratz at CytRx in 2017.